Dr. Bill Tawil has over 20 years of experience in research, business development, and strategy. He is currently director of project management Abbott Medical Laboratories (a St Jude Medical Company). Previously, he worked as a senior scientist at U.S. Surgical Corporation and at Baxter BioSurgery. Before that, he worked in the field of tissue regeneration examining products (synthetic and biologics) that successfully deliver bioactive substances and cells to enhance healing in soft and hard tissue defects. He is on council for the TERMIS NA society and on the Executive Editorial Board for the Tissue Engineering Journal. Bill served on the BOD for the WHS from 2000 to 2005. He was on the Program Committee for the WHS from 1998 – 2000 and again from 2005 – 2008.
Dr. Tawil earned his bachelor degree in biochemistry from UC Berkeley. He completed his master’s and Ph.D. in Neuroscience at McGill University in Montreal studying the expression and function of adhesion cell surface receptors (integrins) in the Central Nervous System and during tumor metastasis. Subsequently, he spent four years of postdoctoral training at the Center for Cancer Research at MIT under the supervision of Dr. Richard Hynes investigating cell adhesion during the cell cycle.